Population-based nutrikinetic modeling of polyphenol exposure

[1]  R. D. de Vos,et al.  Interactions of black tea polyphenols with human gut microbiota: implications for gut and cardiovascular health. , 2013, The American journal of clinical nutrition.

[2]  T. Wiele,et al.  Impact of polyphenols from black tea and red wine/grape juice on a gut model microbiome , 2013 .

[3]  U. Hofmann,et al.  Intestinal absorption, metabolism, and excretion of (-)-epicatechin in healthy humans assessed by using an intestinal perfusion technique. , 2013, The American journal of clinical nutrition.

[4]  B. Bartolomé,et al.  Profiling of microbial-derived phenolic metabolites in human feces after moderate red wine intake. , 2013, Journal of agricultural and food chemistry.

[5]  France Mentré,et al.  Prediction of Shrinkage of Individual Parameters Using the Bayesian Information Matrix in Non-Linear Mixed Effect Models with Evaluation in Pharmacokinetics , 2013, Pharmaceutical Research.

[6]  A. Rodriguez-Mateos,et al.  Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. , 2013, Antioxidants & redox signaling.

[7]  W. D. de Vos,et al.  Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data , 2013, PeerJ.

[8]  T. van de Wiele,et al.  Gut microbial metabolism of polyphenols from black tea and red wine/grape juice is source-specific and colon-region dependent. , 2012, Journal of agricultural and food chemistry.

[9]  S. Moco,et al.  Metabolomics view on gut microbiome modulation by polyphenol-rich foods. , 2012, Journal of proteome research.

[10]  A. Smilde,et al.  Nutrikinetics: concept, technologies, applications, perspectives , 2012 .

[11]  R. Draijer,et al.  Impact of short-term intake of red wine and grape polyphenol extract on the human metabolome. , 2012, Journal of agricultural and food chemistry.

[12]  B. Bartolomé,et al.  Gut microbial catabolism of grape seed flavan-3-ols by human faecal microbiota. Targetted analysis of precursor compounds, intermediate metabolites and end-products , 2012 .

[13]  P. Duke,et al.  The influence of sparse data sampling on population pharmacokinetics: a post hoc analysis of a pharmacokinetic study of morphine in healthy volunteers. , 2012, Clinical therapeutics.

[14]  B. Bartolomé,et al.  In vitro fermentation of a red wine extract by human gut microbiota: changes in microbial groups and formation of phenolic metabolites. , 2012, Journal of agricultural and food chemistry.

[15]  L. Calani,et al.  Identification of microbial metabolites derived from in vitro fecal fermentation of different polyphenolic food sources. , 2012, Nutrition.

[16]  D. Rowan,et al.  Metabolomics for measuring phytochemicals, and assessing human and animal responses to phytochemicals, in food science. , 2012, Molecular nutrition & food research.

[17]  W. D. de Vos,et al.  Intestinal Microbiota in Healthy Adults: Temporal Analysis Reveals Individual and Common Core and Relation to Intestinal Symptoms , 2011, PloS one.

[18]  A. Braune,et al.  Isolation of catechin‐converting human intestinal bacteria , 2011, Journal of applied microbiology.

[19]  Augustin Scalbert,et al.  Dietary intake of 337 polyphenols in French adults. , 2011, The American journal of clinical nutrition.

[20]  E. Zoetendal,et al.  Microarray Analysis and Barcoded Pyrosequencing Provide Consistent Microbial Profiles Depending on the Source of Human Intestinal Samples , 2011, Applied and Environmental Microbiology.

[21]  M. Kussmann,et al.  Plasma pharmacokinetics of catechin metabolite 4′-O-Me-EGC in healthy humans , 2011, European journal of nutrition.

[22]  E. Vaughan,et al.  Novel approaches for analysing gut microbes and dietary polyphenols: challenges and opportunities. , 2010, Microbiology.

[23]  G. Williamson,et al.  Colonic metabolites of berry polyphenols: the missing link to biological activity? , 2010, British Journal of Nutrition.

[24]  C. Kay The future of flavonoid research , 2010, British Journal of Nutrition.

[25]  H. Sies Polyphenols and health: update and perspectives. , 2010, Archives of biochemistry and biophysics.

[26]  T. van de Wiele,et al.  In vitro bioconversion of polyphenols from black tea and red wine/grape juice by human intestinal microbiota displays strong interindividual variability. , 2010, Journal of agricultural and food chemistry.

[27]  Age K. Smilde,et al.  Metabolic fate of polyphenols in the human superorganism , 2010, Proceedings of the National Academy of Sciences.

[28]  E. Zoetendal,et al.  Microbial Community Development in a Dynamic Gut Model Is Reproducible, Colon Region Specific, and Selective for Bacteroidetes and Clostridium Cluster IX , 2010, Applied and Environmental Microbiology.

[29]  Ardiansyah,et al.  Anti-metabolic syndrome effects of adenosine ingestion in stroke-prone spontaneously hypertensive rats fed a high-fat diet , 2010, British Journal of Nutrition.

[30]  Philippe Rocca-Serra,et al.  Challenges of molecular nutrition research 6: the nutritional phenotype database to store, share and evaluate nutritional systems biology studies , 2010, Genes & Nutrition.

[31]  K. Pandey,et al.  Protective effect of resveratrol on markers of oxidative stress in human erythrocytes subjected to in vitro oxidative insult , 2010, Phytotherapy research : PTR.

[32]  J. Hodgson,et al.  A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. , 2009, The Journal of nutrition.

[33]  H. Hara,et al.  High Biliary Excretion Levels of Quercetin Metabolites after Administration of a Quercetin Glycoside in Conscious Bile Duct Cannulated Rats , 2009, Bioscience, biotechnology, and biochemistry.

[34]  J. Espín,et al.  Interaction between phenolics and gut microbiota: role in human health. , 2009, Journal of agricultural and food chemistry.

[35]  W. D. de Vos,et al.  Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults , 2009, Environmental microbiology.

[36]  Age K Smilde,et al.  Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolites. , 2009, Journal of proteome research.

[37]  R. Lamuela-Raventós,et al.  Absorption and pharmacokinetics of green tea catechins in beagles , 2008, British Journal of Nutrition.

[38]  Age K Smilde,et al.  Multilevel data analysis of a crossover designed human nutritional intervention study. , 2008, Journal of proteome research.

[39]  D. Jacobs,et al.  GC-MS methods for metabolic profiling of microbial fermentation products of dietary polyphenols in human and in vitro intervention studies. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[40]  A. Minihane,et al.  Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research , 2007, British Journal of Nutrition.

[41]  B. Biavati,et al.  Biotransformation of common bean (Phaseolus vulgaris L.) flavonoid glycosides by bifidobacterium species from human intestinal origin. , 2007, Journal of agricultural and food chemistry.

[42]  David Heber,et al.  Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. , 2006, The Journal of nutrition.

[43]  C. Kay Aspects of anthocyanin absorption, metabolism and pharmacokinetics in humans , 2006, Nutrition Research Reviews.

[44]  Gary Williamson,et al.  Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. , 2005, The American journal of clinical nutrition.

[45]  Gary Williamson,et al.  Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. , 2005, The American journal of clinical nutrition.

[46]  Liliana Jiménez,et al.  Polyphenols: food sources and bioavailability. , 2004, The American journal of clinical nutrition.

[47]  Susan M Abdel-Rahman,et al.  The integration of pharmacokinetics and pharmacodynamics: understanding dose-response. , 2004, Annual review of pharmacology and toxicology.

[48]  Marie Davidian,et al.  Nonlinear models for repeated measurement data: An overview and update , 2003 .

[49]  F. Nanjo,et al.  Identification of metabolites of (-)-epicatechin gallate and their metabolic fate in the rat. , 2003, Journal of agricultural and food chemistry.

[50]  P. Hollman,et al.  Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. , 2003, The Journal of nutrition.

[51]  A. Braune,et al.  Transformation of flavonoids by intestinal microorganisms. , 2003, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[52]  Sandra N. Mohr,et al.  Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[53]  A. Scalbert,et al.  Absorption and metabolism of polyphenols in the gut and impact on health. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[54]  Chi-Tang Ho,et al.  Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. , 2002, Chemical research in toxicology.

[55]  A. Scalbert,et al.  Catechin is metabolized by both the small intestine and liver of rats. , 2001, The Journal of nutrition.

[56]  J. R. Bell,et al.  Catechin is present as metabolites in human plasma after consumption of red wine. , 1999, The Journal of nutrition.